Atezolizumab Approved for Stage III dMMR Colon Cancer
FDA approved atezolizumab plus chemotherapy after surgery for stage III mismatch-repair-deficient colon cancer, improving three-year disease-free survival and emphasizing biomarker confirmation.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.